Why the study?
Does dipyridamole-echocardiography test predict cardiac events in patients referred for evaluation?
Does dipyridamole-echocardiography test predict cardiac events in patients referred for evaluation?
The presence and timing of transient dyssynergy during dipyridamole stress echocardiography are strong predictors of subsequent cardiac events, outperforming clinical and resting variables.
No takes yet. Share an insight, caveat, or question.
May support risk stratification in referred patients; leaves open prospective validation before practice change.
Picano et al. (1989) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: